Robert Samstein

Mount Sinai Hospital

Full Professor(heuristic)

Cancer Immunotherapy and Biomarkers · Oncology

Compare more Oncology professors.

h-index39
i10-index50
Publications132
Citations18,210

Grants

5 total · 2 active

NIH #R01CA283469

Immunogenetic determinants of cancer risk

Active
Amount
$600K–$700K
Period
2024-06-012029-05-31
PIs
2

Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

NIH #U01CA282114

Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity

Active
Amount
$1M–$2M
Period
2023-09-192028-08-31
PIs
3

Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

NIH #UG3CA290517

Immune determinants modulating cancer development in Lynch Syndrome

Amount
$800K–$900K
Period
2024-06-152026-05-31
PIs
3

Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

5 total · 2 active

NIH #R01CA283469

Immunogenetic determinants of cancer risk

Active
Amount
$600K–$700K
Period
2024-06-012029-05-31
PIs
2

Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

NIH #U01CA282114

Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity

Active
Amount
$1M–$2M
Period
2023-09-192028-08-31
PIs
3

Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

NIH #UG3CA290517

Immune determinants modulating cancer development in Lynch Syndrome

Amount
$800K–$900K
Period
2024-06-152026-05-31
PIs
3

Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

NIH #DP5OD028171

Dissecting the influence of DNA damage response and homologous recombination deficiencies on tumor immunogenicity

Amount
$400K–$500K
Period
2019-09-162024-08-31
PIs
1

Awarded at ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

NIH #F30DK091968

Regulatory T cell control of gut inflammation

Amount
<$100K
Period
2011-07-012015-06-30
PIs
1

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

Recent Public Signals

  1. New paper: Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer (Cell Reports Medicine)2026-05-01
  2. New preprint: Targeting Neoantigens Conserved Across Organs and Species Overcomes Tumor Immune Escape2026-01-01
  3. New NIH award: Immunogenetic determinants of cancer risk2024-06-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-29

Data may not be current

Find elsewhere

ORCID: 0000-0001-6860-2401

Professor Insights

Career Trajectory